» Articles » PMID: 24309187

Remote Ischemic Preconditioning and Renoprotection: from Myth to a Novel Therapeutic Option?

Overview
Specialty Nephrology
Date 2013 Dec 7
PMID 24309187
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

There is currently no effective prophylactic regimen available to prevent contrast-induced AKI (CI-AKI), a frequent and life-threatening complication after cardiac catheterization. Therefore, novel treatment strategies are required to decrease CI-AKI incidence and to improve clinical outcomes in these patients. Remote ischemic preconditioning (rIPC), defined as transient brief episodes of ischemia at a remote site before a subsequent prolonged ischemia/reperfusion injury of the target organ, is an adaptational response that protects against ischemic and reperfusion insult. Indeed, several studies demonstrated the tissue-protective effects of rIPC in various target organs, including the kidneys. In this regard, rIPC may offer a novel noninvasive and virtually cost-free treatment strategy for decreasing CI-AKI incidence. This review evaluates the current experimental and clinical evidence for rIPC as a potential renoprotective strategy, and discusses the underlying mechanisms and key areas for future research.

Citing Articles

Effect of perioperative remote ischemic conditioning on myocardial injury in patients with unstable angina undergoing percutaneous coronary intervention: protocol of a multicenter, randomized, double-blind clinical trial.

Xia L, Yang Q, Jiang L, Zheng Y, Chen L, Lin S Trials. 2025; 26(1):63.

PMID: 39984971 PMC: 11844111. DOI: 10.1186/s13063-025-08744-7.


Effect of remote ischemic preconditioning, nicorandil, and trimetazidine in contrast-induced nephropathy: a network meta-analysis of randomized controlled trials.

Gao H, Li W, Sun C, Zhu S, Liu F, Zhao X Ren Fail. 2024; 46(2):2431141.

PMID: 39604217 PMC: 11610246. DOI: 10.1080/0886022X.2024.2431141.


Arteriovenous Access Creation and eGFR Decline in Patients with CKD.

Tabcheh A, Coscas R, Lambert O, Stengel B, Frimat L, Massy Z J Am Soc Nephrol. 2024; 35(11):1570-1573.

PMID: 39485703 PMC: 11543006. DOI: 10.1681/ASN.0000000000000443.


Do Sodium-Glucose Cotransporter 2 Inhibitors Decrease the Risk of Contrast-Associated Acute Kidney Injury in Patients with Type II Diabetes Mellitus?.

Cabuk G, Hazir K Anatol J Cardiol. 2024; .

PMID: 38506315 PMC: 11059220. DOI: 10.14744/AnatolJCardiol.2024.3980.


Renal vascular responses to angiotensin II infusion in two kidneys-one clip hypertensive rats under partial ischemia/reperfusion with and without ischemia preconditioning: the roles of AT1R blockade and co-blockades of AT1R and MasR.

Karimi F, Nematbakhsh M Res Pharm Sci. 2023; 18(4):392-403.

PMID: 37614612 PMC: 10443668. DOI: 10.4103/1735-5362.378086.


References
1.
Barrier A, Olaya N, Chiappini F, Roser F, Scatton O, Artus C . Ischemic preconditioning modulates the expression of several genes, leading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion. FASEB J. 2005; 19(12):1617-26. DOI: 10.1096/fj.04-3445com. View

2.
Selzner N, Boehnert M, Selzner M . Preconditioning, postconditioning, and remote conditioning in solid organ transplantation: basic mechanisms and translational applications. Transplant Rev (Orlando). 2011; 26(2):115-24. DOI: 10.1016/j.trre.2011.07.003. View

3.
Przyklenk K, Bauer B, Ovize M, Kloner R, Whittaker P . Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993; 87(3):893-9. DOI: 10.1161/01.cir.87.3.893. View

4.
Costa A, Garlid K, West I, Lincoln T, Downey J, Cohen M . Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res. 2005; 97(4):329-36. DOI: 10.1161/01.RES.0000178451.08719.5b. View

5.
Zhong B, Wang D . TRPV1 gene knockout impairs preconditioning protection against myocardial injury in isolated perfused hearts in mice. Am J Physiol Heart Circ Physiol. 2007; 293(3):H1791-8. DOI: 10.1152/ajpheart.00169.2007. View